Related references
Note: Only part of the references are listed.Effect of pharmacogenetic variations on praziquantel plasma concentration and safety outcomes among school children in Rwanda
Abbie Barry et al.
SCIENTIFIC REPORTS (2023)
Efficacy and safety of praziquantel preventive chemotherapy in Schistosoma mansoni infected school children in Southern Ethiopia: A prospective cohort study
Tigist Dires Gebreyesus et al.
FRONTIERS IN PHARMACOLOGY (2023)
Prevalence and Determinants of Schistosoma mansoni Infection among Pre-School Age Children in Southern Ethiopia
Tafese Tadele et al.
PATHOGENS (2023)
Effect of preventive chemotherapy with praziquantel on schistosomiasis among school-aged children in sub-Saharan Africa: a spatiotemporal modelling study
Christos Kokaliaris et al.
LANCET INFECTIOUS DISEASES (2022)
Safety of Praziquantel and Albendazole Coadministration for the Control and Elimination of Schistosomiasis and Soil-Transmitted Helminths Among Children in Rwanda: An Active Surveillance Study
Joseph Kabatende et al.
DRUG SAFETY (2022)
Safety Surveillance of Mass Praziquantel and Albendazole Co-Administration in School Children from Southern Ethiopia: An Active Cohort Event Monitoring
Tigist Dires Gebreyesus et al.
JOURNAL OF CLINICAL MEDICINE (2022)
Effect of Dihydroartemisinin-Piperaquine on the Pharmacokinetics of Praziquantel for Treatment of Schistosoma mansoni Infection
Omary Mashiku Minzi et al.
PHARMACEUTICALS (2021)
Effect of Pharmacogenetics Variations on Praziquantel Plasma Concentrations and Schistosomiasis Treatment Outcomes Among Infected School-Aged Children in Tanzania
Rajabu Hussein Mnkugwe et al.
FRONTIERS IN PHARMACOLOGY (2021)
Schistosomiasis with a Focus on Africa
Oyime Poise Aula et al.
TROPICAL MEDICINE AND INFECTIOUS DISEASE (2021)
Efficacy and Safety of Praziquantel for Treatment of Schistosoma mansoni Infection among School Children in Tanzania
Rajabu Hussein Mnkugwe et al.
PATHOGENS (2020)
Nationwide Remapping of Schistosoma mansoni Infection in Rwanda Using Circulating Cathodic Antigen Rapid Test: Taking Steps toward Elimination
Eugene Ruberanziza et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2020)
Evaluation of the therapeutic efficacy of praziquantel against schistosomes in seven countries with ongoing large-scale deworming programs
B. Levecke et al.
INTERNATIONAL JOURNAL FOR PARASITOLOGY-DRUGS AND DRUG RESISTANCE (2020)
Prevalence, Intensity, and Correlates of Soil-Transmitted Helminth Infections among School Children after a Decade of Preventive Chemotherapy in Western Rwanda
Joseph Kabatende et al.
PATHOGENS (2020)
Prevalence, Intensity, and Correlates of Schistosomiasis and Soil-Transmitted Helminth Infections after Five Rounds of Preventive Chemotherapy among School Children in Southern Ethiopia
Tigist Dires Gebreyesus et al.
PATHOGENS (2020)
Efficacy and safety of praziquantel and dihydroartemisinin piperaquine combination for treatment and control of intestinal schistosomiasis: A randomized, non-inferiority clinical trial
Rajabu Hussein Mnkugwe et al.
PLOS NEGLECTED TROPICAL DISEASES (2020)
Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomes in sub-Saharan Africa: a systematic review
Muhubiri Kabuyaya et al.
INFECTIOUS DISEASES OF POVERTY (2018)
Efficacy of praziquantel treatment regimens in pre-school and school aged children infected with schistosomiasis in sub-Saharan Africa: a systematic review
Muhubiri Kabuyaya et al.
INFECTIOUS DISEASES OF POVERTY (2018)
Anemia and growth retardation associated with Schistosoma haematobium infection in Mali: a possible subtle impact of a neglected tropical disease
Chalotte W. Stecher et al.
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2017)
Schistosomiasis and soil-transmitted helminthiasis in Rwanda: an update on their epidemiology and control
Nadine Rujeni et al.
INFECTIOUS DISEASES OF POVERTY (2017)
Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial
Jean T. Coulibaly et al.
LANCET GLOBAL HEALTH (2017)
Impact of human schistosomiasis in sub-Saharan Africa
Abiola Fatimah Adenowo et al.
BRAZILIAN JOURNAL OF INFECTIOUS DISEASES (2015)
The roles of water, sanitation and hygiene in reducing schistosomiasis: a review
Jack E. T. Grimes et al.
PARASITES & VECTORS (2015)
Susceptibility or resistance of praziquantel in human schistosomiasis: a review
Wei Wang et al.
PARASITOLOGY RESEARCH (2012)
Utility of Repeated Praziquantel Dosing in the Treatment of Schistosomiasis in High-Risk Communities in Africa: A Systematic Review
Charles H. King et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Interpreting low praziquantel cure rates of Schistosoma mansoni infections in Senegal
A Danso-Appiah et al.
TRENDS IN PARASITOLOGY (2002)
Are poor responses to praziquantel for the treatment of Schistosoma mansoni infections in Senegal due to resistance?: An overview of the evidence
B Gryseels et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2001)